Trump Admin Discusses FDA Leadership Changes

Trump administration officials, including Health Secretary Robert F. Kennedy Junior, have been discussing changes to the role of U.S. Food and Drug Administration commissioner, Marty Makary. The proposed changes involved appointing someone to manage daily operations, leaving Makary in a ceremonial position due to internal disagreements. However, these plans have been put on hold, giving Makary a chance to improve his leadership and address concerns. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.